Cue Biopharma (CUE) Cash from Investing Activities Growth (3y) (2020 - 2025)
Cue Biopharma (CUE) Cash from Investing Activities Growth (3y) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
116.52% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
38.24% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Cue Biopharma |
581.16 Mn |
553.47 Mn |
- |
11.98% |
| Date | Value |
|---|
| Dec 31, 2025 |
11.98% |
| Sep 30, 2025 |
38.80% |
| Jun 30, 2025 |
24.20% |
| Mar 31, 2025 |
-77.11% |
| Dec 31, 2024 |
-58.17% |
| Sep 30, 2024 |
121.78% |
| Jun 30, 2024 |
64.99% |
| Mar 31, 2024 |
-26.12% |
| Sep 30, 2023 |
2.42% |
| Jun 30, 2023 |
235.35% |
| Mar 31, 2023 |
51.94% |
| Dec 31, 2022 |
32.57% |
| Sep 30, 2022 |
-111.12% |
| Jun 30, 2022 |
-26.25% |
| Mar 31, 2022 |
-26.05% |
| Dec 31, 2021 |
-95.22% |
| Sep 30, 2021 |
92.25% |
| Jun 30, 2021 |
32.57% |
| Mar 31, 2021 |
151.44% |
| Dec 31, 2020 |
705.82% |
